<DOC>
	<DOCNO>NCT00312806</DOCNO>
	<brief_summary>The aim present study identify factor ( symptom pattern symptom score ) influence response treatment pantoprazole use different evaluation method ( e.g. , ReQuestâ„¢ questionnaire , patient investigator assessment ) . Pantoprazole administer daily morning one dose level . The study duration consist treatment period 8 week . The study provide data safety tolerability pantoprazole .</brief_summary>
	<brief_title>Effect Pantoprazole Symptoms Acid Reflux Disease Adult Patients ( BY1023/M3-341 )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main Written inform consent Outpatients least 18 year ( 21 year Argentina ) Patient consider GERD symptom Main Acute peptic ulcer and/or ulcer complication Systemic glucocorticoid nonsteroidal antiinflammatory drug ( NSAIDs ) include COX2inhibitors ( &gt; 5 day demand 3 consecutive day ) last 28 day study start ( except regular intake acetylsalicylic acid dose 163 mg/day ) Intake proton pump inhibitor last 10 day study start Female patient childbearing potential use adequate mean birth control Pregnant breastfeeding female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Gastroesophageal Reflux Disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Pantoprazole</keyword>
	<keyword>ReQuestTM</keyword>
</DOC>